➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
AstraZeneca
Dow
Mallinckrodt
Harvard Business School
McKinsey

Last Updated: September 18, 2020

DrugPatentWatch Database Preview

Patent: 8,183,041

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,183,041
Title:Method of tissue repair using a multi-layered matrix
Abstract: A multi-layered matrix, a method of tissue repair using the same, and multi-layered implant prepared thereof are provided. The multi-layered matrix comprises a first element and a second element connected thereto, and the second element comprises a hollow cavity. The first and the second elements are composed of a composite material comprising a bioabsorbable porous material.
Inventor(s): Liao; Chun-Jan (Taipei, TW), Jiang; Ching-Chuan (Taipei, TW), Chiang; Hong-Sen (Taipei, TW), Lin; Yu-Ru (Ilan, TW)
Assignee: Industrial Technology Research Institute (Hsinchu, TW) National Taiwan University Hospital (Taipei, TW)
Application Number:12/385,775
Patent Claims:see list of patent claims

Details for Patent 8,183,041

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Bausch And Lomb VITRASE hyaluronidase INJECTABLE;INJECTION 021640 001 2004-12-21   Start Trial Industrial Technology Research Institute (Hsinchu, TW) National Taiwan University Hospital (Taipei, TW) 2025-12-29 RX search
Bausch And Lomb VITRASE hyaluronidase INJECTABLE;INJECTION 021640 002 2004-12-21   Start Trial Industrial Technology Research Institute (Hsinchu, TW) National Taiwan University Hospital (Taipei, TW) 2025-12-29 RX search
Amphastar Pharm AMPHADASE hyaluronidase INJECTABLE;INJECTION 021665 001 2005-11-03   Start Trial Industrial Technology Research Institute (Hsinchu, TW) National Taiwan University Hospital (Taipei, TW) 2025-12-29 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Colorcon
Medtronic
Merck
Harvard Business School
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.